Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 43Active not recruiting 27Not yet recruiting 4Terminated 3Completed 2Withdrawn 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 72Neoplasms 50Prostatic Neoplasms 36Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 25Lung Neoplasms 23Multiple Myeloma 19Head and Neck Neoplasms 19Leukemia, Myeloid, Acute 17Squamous Cell Carcinoma of Head and Neck 15Pancreatic Neoplasms 15Neoplasm Metastasis 13Carcinoma, Hepatocellular 13Stomach Neoplasms 12Recurrence 12Ovarian Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Non-Hodgkin 10Lymphoma, Follicular 10Carcinoma, Renal Cell 10Rectal Neoplasms 9Lymphoma 9Brain Neoplasms 9Sarcoma 8Melanoma 8Lymphoma, Large B-Cell, Diffuse 8Kidney Neoplasms 8Colonic Neoplasms 8Motor Activity 7Liver Neoplasms 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × 30 days × Clear all
NCT03049410 2026-05-12

iROC

University College, London

Phase NA Completed
339 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT07568444 2026-05-06

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

University of Southern California

Phase 2 Completed
120 enrolled
Genitourinary

Adenocarcinoma, Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡